Sources: US News
Health Canada approves the use of Pfizer's anti-COVID-19 viral drug Paxlovid for people over the age of 18 years who are at risk of severe disease and death. 2022-01-17
BioNTech CEO Uğur Şahin and Pfizer CEO Albert Bourla both say that their vaccine is likely to be effective against severe disease resulting from the Omicron variant. 2021-11-30
South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 as part of a plan to administer 50 million "booster" doses of the vaccine. 2021-08-13
The government signs an agreement with Pfizer to purchase 40 million doses of the Pfizer–BioNTech vaccine, the Philippines' largest supply agreement for a COVID-19 vaccine. 2021-05-17
In a study published by the National Health Service, the Pfizer vaccine has been found to reduce hospitalizations in elderly people by 75%. 2021-04-14
South Korea signs an agreement with Novavax and Pfizer to secure additional doses of the COVID-19 vaccine for 23 million people in the second quarter of this year. 2021-02-16
The Netherlands begins a vaccination programme against COVID-19 with a nurse becoming the first person to be vaccinated with Pfizer's Tozinameran vaccine. 2021-01-6
Ireland officially begins a vaccination programme against COVID-19 using Pfizer-BioNTech's tozinameran vaccine, with a 79-year-old woman from Dublin becoming the first person to receive the vaccine. 2020-12-29
Kuwait's Ministry of Health approves an Emergency Use Authorization of the Pfizer-BioNtech vaccine. 2020-12-13
Malaysia's Health Ministry signs a preliminary purchasing agreement with Pfizer to obtain 12.8 million doses of COVID-19 vaccines. 2020-11-27